Ashida A - Search Results

1

NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression.

Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, Goto Y, Shang WH, Kubodera M, Kato M, Takata M, Saida T, Kamata T. Yamaura M, et al. Among authors: ashida a. Cancer Res. 2009 Mar 15;69(6):2647-54. doi: 10.1158/0008-5472.CAN-08-3745. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276355

2

Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas.

Murata H, Ashida A, Takata M, Yamaura M, Bastian BC, Saida T. Murata H, et al. Among authors: ashida a. Cancer Sci. 2007 Jul;98(7):958-63. doi: 10.1111/j.1349-7006.2007.00496.x. Epub 2007 May 4. Cancer Sci. 2007. PMID: 17488338 Free PMC article.

3

Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.

Kubo H, Ashida A, Matsumoto K, Kageshita T, Yamamoto A, Saida T. Kubo H, et al. Among authors: ashida a. Arch Dermatol Res. 2008 Jul;300(6):297-301. doi: 10.1007/s00403-008-0841-6. Epub 2008 Mar 7. Arch Dermatol Res. 2008. PMID: 18324409

4

Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.

Ashida A, Takata M, Murata H, Kido K, Saida T. Ashida A, et al. Int J Cancer. 2009 Feb 15;124(4):862-8. doi: 10.1002/ijc.24048. Int J Cancer. 2009. PMID: 19035443 Free article.

5

A case of epidermolysis bullosa acquisita associated with laryngeal stenosis.

Kiniwa Y, Ashida A, Ohashi A, Kitoh R, Fukuda S, Hashimoto T, Okuyama R. Kiniwa Y, et al. Among authors: ashida a. Acta Derm Venereol. 2012 Jan;92(1):93-4. doi: 10.2340/00015555-1163. Acta Derm Venereol. 2012. PMID: 22215014 Free article. No abstract available.

6

NRAS mutations in primary and metastatic melanomas of Japanese patients.

Uhara H, Ashida A, Koga H, Ogawa E, Uchiyama A, Uchiyama R, Hayashi K, Kiniwa Y, Okuyama R. Uhara H, et al. Among authors: ashida a. Int J Clin Oncol. 2014;19(3):544-8. doi: 10.1007/s10147-013-0573-2. Epub 2013 Jun 6. Int J Clin Oncol. 2014. PMID: 23739925

7

5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.

Uchiyama R, Uhara H, Uchiyama A, Ogawa E, Takazawa Y, Ashida A, Koga H, Hayashi K, Kiniwa Y, Okuyama R. Uchiyama R, et al. Among authors: ashida a. J Dermatol Sci. 2014 Feb;73(2):161-3. doi: 10.1016/j.jdermsci.2013.09.008. Epub 2013 Oct 10. J Dermatol Sci. 2014. PMID: 24169492 No abstract available.

8

Toll-like receptor 4 signaling promotes the migration of human melanoma cells.

Takazawa Y, Kiniwa Y, Ogawa E, Uchiyama A, Ashida A, Uhara H, Goto Y, Okuyama R. Takazawa Y, et al. Among authors: ashida a. Tohoku J Exp Med. 2014 Sep;234(1):57-65. doi: 10.1620/tjem.234.57. Tohoku J Exp Med. 2014. PMID: 25175033 Free article.

9

Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma.

Ashida A, Sakaizawa K, Mikoshiba A, Kiniwa Y, Okuyama R. Ashida A, et al. Acta Derm Venereol. 2019 Nov 1;99(12):1184-1185. doi: 10.2340/00015555-3279. Acta Derm Venereol. 2019. PMID: 31396634 Free article. No abstract available.

10

BRAF Mutation Heterogeneity in Melanoma Lesions.

Sakaizawa K, Ashida A, Kiniwa Y, Okuyama R. Sakaizawa K, et al. Among authors: ashida a. Acta Derm Venereol. 2020 Jan 30;100(1):adv00045. doi: 10.2340/00015555-3394. Acta Derm Venereol. 2020. PMID: 31821518 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters